| Financial Year |
March 31 2023 |
| Monetary Funds |
272,865,094.74 |
| Held-for-trading Financial Assets |
50,000,000.00 |
| Notes Receivable |
43,114,060.13 |
| Accounts Receivable |
133,164,057.77 |
| Advances to Suppliers |
25,895,649.50 |
| Other Receivables |
173,028,460.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
126,619,887.21 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,555,548.25 |
| Total Current Assets |
837,392,093.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
41,359,957.28 |
| Investment Properties |
67,577,422.79 |
| Fixed Assetes |
1,290,928,674.64 |
| Under-construction Projects |
305,021,581.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
5,883,990.44 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
315,947,593.69 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
11,173,589.31 |
| Deferred Income Tax Assets |
65,314,357.03 |
| Other Non-Current Assets |
23,060,074.26 |
| Sub-Total of Non-Current Assets |
2,143,530,523.05 |
| Total Assets |
2,980,922,616.16 |
| Short-Term Loans |
125,431,995.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
59,864,610.22 |
| Accounts Received In Advance |
737,821.10 |
| Employee Compensation Payable |
7,697,486.77 |
| Taxes Payable |
6,849,649.44 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
146,880,157.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
86,880,930.49 |
| Other Current Liabilities |
12,681,723.50 |
| Sub-Total of Current Liabilities |
471,133,370.54 |
| Long-term Loans |
140,288,890.70 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
62,712,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
4,537,648.34 |
| Deferred Income Tax Liabilities |
1,863,445.34 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
336,970,365.55 |
| Total Liabilities |
808,103,736.09 |
| Paid-In Capital(Or Share Stock) |
318,000,000.00 |
| Capital Surplus |
1,400,779,329.86 |
| Surplus Reserve |
141,719,599.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
304,621,459.38 |
| Minority Stockholder's Interest |
4,766,648.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,168,052,231.84 |
| Owner's Equity（Stockholder's Equity） |
2,172,818,880.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,980,922,616.16 |
